CUMBERLAND PHARMACEUTICALS INC. will begin distributing Ethyol (amifostine) for injection to U.S. wholesalers. Ethyol is an FDA approved cytoprotective drug indicated to reduce the incidence of xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer. It also reduces the cumulative renal toxicity associated with the repeated administration of cisplatin in patients with...
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
